Main Topics:
Refractive Surgery Complications managements
Dry Eye therapeutic management update
Live streaming sessions – Friday
Chairs: M. Morral, M. Labetoulle
Chairs: D. Elies, P. Vinciguerra
Chairs: J. Güell, R. Nuijts
Chairs: M. Barbany, B.Cochener
Live streaming sessions – Saturday
Chairs: R. Nuijts, H. Dua , D. Elies, M. Barbany, M. Morral, J. Güell
Coordinators: D. Elies, M. Barbany, M. Morral, J. Güell
A.- OCULAR SURFACE
Chairs: M. Barbany, M. Morral, J. Güell, H. Dua, J. Alvarez de Toledo, M. Labetoulle, J. Hjortdal
Coordinators: D. Elies, M. Barbany, M. Morral, J. Güell
B.- REFRACTIVE SURGERY COMPLICATIONS
Chairs: D. Elies, J. Güell, P. Vinciguerra, F. Malecaze, B. Allan, R. Nuijts, L. Mastropasqua
Organiser
Director
ESASO Anterior Segment Academy
Director of Cornea and Refractive Surgery Unit – Instituto Microcirugia Ocular (IMO), Barcelona, Spain
Director
ESASO Anterior Segment Academy
Director of the Ophthalmology Department
Humanitas University, Milan, Italy
ESASO Global Executive Director
Lugano, Switzerland
Scientific Programme
Friday, 5th April
09.00 – 09.10 WELCOME
09.10 – 09.20 Mebomian Gland Dysfunction: evaluation tools including HD Analyzer and Topographer – M. Morral
09.20 – 09.30 Beyond BUT: HD Analyzer tear film evaluation – R. Zaldivar
09.30 – 09.40 Update in calibrating ocular surface inflammation – M. Labetoulle
09.40 – 09.50 Neurothrophic Keratopathy: measuring a devastating surgical and non-surgical complication – H. Dua
09.50 – 10.00 The new trend in technology: OCT based, and scheimplug based integrated biometer – P. Rosetta
10.00 – 10.30 DISCUSSION
10.30-11.00 BREAK
11.00 – 11.10 Individualized corneal laser treatments after corneal refractive procedures – P. Vinciguerra
11.10 – 11.20 LASIK complications: how to avoid and treat problems – B. Allan
11.20 – 11.30 How to manage SMILE complications – L. Mastropasqua
11.30 – 11.40 Corneal refractive Surgery and herpes disease – N. Alexandre
11.40 – 11.50 Indications of keratoplasty techniques after corneal refractive surgery – C. Cursifien
11.50 – 12.00 Complications rate comparison between mechanical and femtosecond microkeratomes – F. Malecaze
12.00 – 12.10 Intracorneal lenses are they a safe surgical strategy – B. Cochener
12.10 – 12.40 DISCUSSION
12.40 – 13.40
13.40 – 14.00
14.00 – 14.10 How to understand the unexpected visual symptoms with modern diagnostic technology – P. Vinciguerra
14.10 – 14.20 Managing postoperative error with Toric IOL patients: pearls for success – R. Nuijts
14.20 – 14.30 Postoperative Corneal edema: prevention and management and its impacts on IOP measurement – M. Angeles del Buey
14.30 – 14.40 IOL exchange: a relatively common procedure – S. Morselli
14.40 – 14.50 Long-term endothelial cell loss after iris fixated phakic IOL implantation – R. Nuijts
14.50 – 15.00 Fixing refractive surgery complications with phototherapeutics ablation – R. Vinciguerra
15.00 – 15.10 Prevention and management of ICL complications – F. Duch
15.10 – 15.50 DISCUSSION
15.50 – 16.00 Pterigium surgery: how to prevent and how to treat recurrence – H. Dua
16.00 – 16.10 Use of growth-factors-enriched autologous plasma in persistent corneal epithelial defects – J. Alvarez de Toledo
16.10 – 16.20 Terrien disorder: a management update – T. Sabala
16.20 – 16.30 Update in ocular surface reconstruction techniques: the role of keratoplasty – J. Hjortdal
16.30 – 16.40 Management of MGD – B. Cochener
16.40 – 16.50 Special devasting situations in herpes diseases – M. Labetoulle
16.50 – 17.20 DISCUSSION
17.20 – 17.40 New Anterion (OCT based topo/tomographer and biometer) (NO CME) – P. Vinciguerra
Saturday, 6th April
CASES 3D Y 2D: Refractive surgery complication management and what’s new in ocular surface
09.00 – 09.10 D. Elies
09.10 – 09.20 M. Barbany
09.20 – 09.30 M. Morral
09.30 – 09.40 J. Güell
09.40 – 10.10 DISCUSSION
10.10 – 10.15 Ocular Surface papilloma: ten years to treat – H. Dua
10.15 – 10.20 Homologous PKP for multiple rejection – S. Morselli
10.20 – 10.25 Bilateral Corneal Toxicity with 100% chlorhexidine in blepharoplasty – J. Alvarez de Toledo
10.25 – 10.30 Neurothrophic Corneal perforation after PK: Fibrin glue, AM and large diameter DALK – N. Alexandre
10.30 – 10.35 Nightmare after pseudopterygium surgery on a xeroderma pigmentation patient – M. Garat
10.35 – 10.40 Ocular Surface complication managment – L. Mastropasqua
10.40 – 10.45 Ocular Surface complication managment – D. Said
10.45 – 11.15 DISCUSSION
11.15 – 11.30 BREAK
11.30 – 11.35 Laser Corneal refractive surgery complications case report – F. Malecaze
11.35 – 11.40 Toric Artifex post keratoplasty – J.L. Güell
11.40 – 11.45 LASIK Complication – R. Zaldivar
11.45 – 11.50 Corneal refractive surgery complication managment – P. Vinciguerra
11.50 – 11.55 Post LASIK complete flap traumatic loss – M. Angeles del Buey
11.55 – 12.00 Case report: Management of potsrefractive surgery irregular astigmatism – B. Allan
12.00 – 12.05 Decreased vision after Toric and multifocal piggy-back implantation – R. Nuijts
12.05 – 12.10 Corneal refractive surgery complication management – M. Nubile
12.10 – 13.00 DISCUSSION & CLOSURE OF THE MEETING
Master Classes
Friday, April 5th, 2019
Supported by Sooft
Course duration 1 hours
Directors: L. Mastropasqua, M. Nubile
Programme
12:40 – 12:50 Update in Diagnosis and current definition of progressive keratoconus – Nataliia Malachkova
12:50 – 13:00 Corneal Collagen cross linking: from Iontophoresis to combined techniques – Mario Nubile
13:00 – 13:10 Femtosecond laser technology in intrastromal keratoplasty for corneal ectasia (SLAK)- Leonardo Mastropasqua
13:10 – 13:20 Deep anterior lamellar keratoplasty: from basics to the latest evolution in surgical techniques – Ozana Manuela Moraru
13:20 – 13:40 Interactive discussion with participants
DESCRIPTION
The aim of the master class “Updates on diagnosis and management of keratoconus” is to provide to the participating ophthalmologists a comprehensive description of the diagnostic procedure to detect keratoconus progression and overview of the current methods available in the surgical scenario with particular emphasis on high-tech instrumentation and latest development. Selected clinical cases will be presented and discussed with participants.
OBJECTIVES
Upon completion of the master class, the learner should:
- have a better understanding of the diagnosis and follow-up of keratoconus patient
- be able to discriminate clinical progressive disease
- have a better knowledge of current therapeutic options (beyond optical correction with spectacles or contact lenses) among the latest advances in surgical procedures
TOPICS
- Keratoconus management
- Tomographical diagnosis of keratoconus
- Detections of keratoconus progression
- Corneal Collagen cross-linking indications and literature review
- Iontophoresis assisted cross-linking in keratoconus
- Combined refractive surgical techniques with cross-linking
- Femtosecond laser technology in Intrastromal keratoplasty
- Corneal remodelling (Stromal lenticule addition keratoplasty: SLAK)
- Intraoperative OCT in Deep anterior lamellar keratoplasty
Teaching staff
Leonardo Mastropasqua
Ozana Moraru
Nataliia Malachkova
Friday, April 5th, 2019
With the unconditional contribution of Dompé farmaceutici
Course duration 1 hours
Directors: L. Mastropasqua, H.S. Dua
Programme
12:40 – 12:50 Definition and Clinical presentation and staging of Neurotrophic Keratopathy – Harminder S. Dua
12:50 – 13:00 Basic and advanced diagnostic procedures and differential diagnosis of NK – Dalia Said
13:00 – 13:10 Conventional medical treatment and surgical indications in NK – Mario Nubile
13:10 – 13:20 Innovations in NK treatment with topical NGF: evidences, results and perspectives – Leonardo Mastropasqua
13:20 – 13:40 Interactive discussion with participants
DESCRIPTION
The aim of this master class “Neurotrophic keratopathy: innovations in diagnosis and treatment” is to describe to the participating ophthalmologists recent updates on neurotrophic keratopathy (NK) including definition, classification and staging, diagnosis, complications, medical management and surgical treatment. Particular emphasis will be dedicated to differential diagnosis and to the presentation of recent NGF on-label treatment available for this orphan disease. and Selected clinical cases will be presented and discussed with participants.
OBJECTIVES
Upon completion of the master class, the learner should:
- have a better knowledge of neurotrophic keratopathy
- be able to perform correct differential diagnosis of the diseases and correct diagnostic algorithm for severity staging
- be able to perform correct therapeutic approach considering medical conservative, etiological treatment, and surgical indications.
TOPICS
- Neurotrophic Keratopathy
- Definition of NK
- Clinical presentation
- Diagnostic algoithm
- Differential diagnosis
- Complications
- Conventional conservative treatment
- NGF (Nerve Growth Factor) topical treatment
- Surgical Procedures
Teaching staff
Leonardo Mastropasqua
Harminder S. Dua
Mario Nubile
Dalia Said
UEMS/EACCME Accreditation:
“The 5th ESASO Anterior Segment Academy, Barcelona, Spain, 05/04/2019-06/04/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 8 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”
“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities. “Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”

Location
Barcelona, the capital of Catalonia, is a Mediterranean and cosmopolitan city with Roman remains, medieval quarters and the most beautiful examples of 20th century Modernism and avant-garde. It is no surprise that emblematic constructions by the Catalan architects Antoni Gaudí and Lluís Doménech i
Montaner have been declared World Heritage Sites by UNESCO. The city’s origins are Roman, and its long history and economic dynamism have made Barcelona a cultural city, which can be seen in the historic-artistic heritage and the promotion of the most innovative artistic trends. A wide cultural programme will take visitors to museums, exhibitions, open-air sculptures and many concerts, plays and dances.
Strolling around the streets of Barcelona brings surprises at every turn. Pedestrian streets in the old quarter, green spaces, and a splendid seafront with a range of modern facilities are a reflection of its multi-faceted character. Barcelona has cleverly succeeded in embracing its past without forgetting its commitment to the future.
Instituto de Microcirugía Ocular (IMO)
Carrer Josep Maria Lladó, 3, 08035 Barcelona, Spain
www.imo.es
For over 25 years, IMO has sought to find solutions to all ocular disorders through the expert application of the best treatments. It has a highly specialised and committed medical team, the most advanced technology and spacious, comfortable and modern facilities. IMO is driven by medical excellence and quality customer service, embodied in a team committed to optimal patient care.
On-going training and research are other cornerstones of IMO medical commitment. They enable IMO to discover new therapeutic opportunities and make advances in the diagnosis and treatment of eye problems in a pioneering and effective manner.
The IMO is located near Junction 7 of Barcelona’s Ronda de Dalt ring road (mountain side) and can be accessed directly from Josep Maria Llado street.
Nearest bus stations:
- Rotonda de Bellesguard. Bus 60. Bus stop 1540
- Ronda de Dalt – Bellesguard. Buses 60, 123, 196. Bus stop 0071
Invitation Letter / VISA
All foreigners intending to enter Spain must provide the documentation required to justify the reasons and duration of their stay as well as, in some prescribed cases, the availability of adequate economic means and lodging. If you need a visa, the application can be made at the Spanish Diplomatic and Consular Representations in your country of residence.
Don’t you have an EU passport or EU valid documentation?
Do you need a Visa ?
If you have doubts visit NOW the website of the Spanish Ministry of Foreign Affairs:
http://www.exteriores.gob.es/Portal/en/ServiciosAlCiudadano/InformacionParaExtranjeros/Paginas/Inicio.aspx
- find out whether, depending on your citizenship, country of long-term residence, and the duration and
reasons for your stay, you need a Visa to enter Spain. - find out which documents are required in order to apply for your visa.
ATTENTION:
- VISA application may even require 120 days! Check it NOW!
- VISA application fee is from Euro 35,00 to Euro 116,00 per person to be paid at application, in local
currency, to the Consulate or Embassy directly. - presentation of the documentation requested does not necessarily ensure issuance
of the VISA
AIM Group will be glad to assist you if you need any written invitation or other document to support your VISA Application.
Feel free to contact us at visa@aimgroup.eu
If you are requested to have an invitation letter of the conference you can easily print it online once finalized your registration. Invitation letter is available only for regular participants whose payment is received by the Organizing Secretariat.
Invitation letter may not be enough to obtain VISA to enter Spain.
We recommend to check your VISA status carefully when evaluating to register to the conference.
Sponsor
The ESASO Congress of Anterior Segment Academy, adheres to current industry compliance guidelines and follows transparency and integrity policies. The organization interacts with the industry on an ethical, appropriate and professional level at all times.
The ESASO Congress of Anterior Segment Academy will be assessed by the following industry associations:
EFPIA, e4ethics
Eucomed, EthicalMedTech
For details regarding sponsorship and exhibition opportunities, please contact:
Ms. Barbara Casirani
Tel. +39 02 56601.233
Fax +39 02 70048578
b.casirani@aimgroup.eu

Contacts
IMO Instituto de Microcirugia Ocular
Carrer Josep Maria Lladó, 3
08035 Barcelona, Spain
Barbara Casirani
Elisabetta Di Felice
congress.asa@esaso.org
Tel.: +39 02 56601 1
Fax: +39 02 56609045
info@esaso.org
Tel: +41 (0)91 921 1154
Fax: +41 (0)91 921 11 25
www.esaso.org